Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-016860
Filing Date
2017-03-02
Accepted
2017-03-02 17:56:30
Documents
2
Period of Report
2017-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4631
2 POA DOCUMENT poa.txt EX-24.4_708179 892
  Complete submission text file 0001209191-17-016860.txt   7066
Mailing Address 1185 AVENUE OF THE AMERICAS NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS NEW YORK NY 10036 2129978500
HESS CORP (Issuer) CIK: 0000004447 (see all company filings)

EIN.: 134921002 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2911 Petroleum Refining

Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Quigley James H. (Reporting) CIK: 0001554331 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-01204 | Film No.: 17660487